The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.

But hundreds of thousands of people globally each year won’t survive their bouts with the flu, and millions more will suffer ...

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The Pfizer-developed vaccine was found to be 34.5 percent more effective than ...

Moderna MRNA announced that it submitted regulatory filings seeking approval for its seasonal influenza vaccine mRNA-1010 ...

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS ...

In early January 2026, Moderna filed for marketing authorization of its investigational seasonal influenza vaccine mRNA-1010 ...

Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research into a potential bird flu mRNA vaccine, helping to recover some of the ...

Editorial: Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology un ...

The U.S. is facing its worst flu season in 25 years, according to the Centers for Disease Control and Prevention, which ...

OUR SON SWEARS BY HIS WEIGHTED VEST. HE WEARS IT ALL THE TIME. A FIRE ON YOUR HEALTH TONIGHT. BUILDING A BETTER FLU SHOT, RESEARCHERS SAY AT PFIZER THAT THEY HAVE DONE IT. THEY’RE USING MRNA PLATFORM ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El ...